Primary Immunodeficiency 31/01/23 Flashcards

1
Q

What is the definition of an immunodeficiency?

A

Immunodeficiency is defined as disease characterised by absence or failure of any part of the immune system.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the definition of a primary immunodeficiency?

A

Immunodeficiencies that are caused by genetic defects that disable parts of the immune network (a failure within the immune system itself).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the basis of the immune system?

A

Pluripotent haematopoietic stem cells in the bone marrow differentiate via the myeloid or lymphoid pathway into the various immune cells. Immune cells migrate from blood circulation into the tissues, using cell adhesion molecules, chemotactic factors and complement proteins that regulate the inflammatory response. After entering tissues, phagocytic cells, part of the innate immune response, engulf pathogens by phagocytosis and destroy them with lots of different microbicidal agents.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the function of natural killer cells?

A

Natural Killer cells deal with intracellular infections (phagocytes, complement, and antibodies cannot access pathogens once inside the cell). NK cells are also part of the innate immune response. NK cell are large granular leukocyte that does not rearrange nor express either Ig or T cell receptor genes. It recognizes virally infected cells and tumour cells in an major histocompatibility complex and antibody dependent manner. NK cells can also mediate antibody-dependent cellular cytotoxicity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the adaptive immune system?

A

Adaptive immunity (antibody producing B cells, helper, cytotoxic and regulatory T cells) provides back-up to the innate response such as natural killer cells. The adaptive immunity takes a while to develop (much quicker secondary responses than initial encounter with a pathogen). Antibodies have neutralizing function as well as function as opsonin. Cytotoxic T cells destroy infected/abnormal cells by specific binding to the major histocompatibility complex and fragmenting.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What risk does a immunodeficiency disease cause to the individual?

A

They are at risk of opportunistic infections which are caused by microorganisms that healthy individuals can easily get rid of but that cause disease and even death in those with significantly impaired immune function.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

When was the first immunodeficiency disease discovered?

A

Before antibiotics were used in the 1950s most patients with immunodeficiencies died during infancy or early childhood. Since so many infants died before antibiotics were used death caused by immunodeficiencies did not become apparent until the introduction of antibiotics so this was when the first primary immunodeficiency was diagnosed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What causes an immunodeficiency disease?

A

Genetic or developmental defects such as a missing enzyme, cell type, or non-functioning component can cause immunodeficiency.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Who is affected by immunodeficiency and what genes are involved?

A

Defects of virtually any gene involved in immune development or function can cause these diseases. Mutant alleles have been found in most genes encoding components of the immune system and immunologists have learnt a lot about the functions of genes from looking at the types of infections patients with defective alleles have-in a similar manner to mouse knock-out models.

Those effected at birth have a congenital (defect present at birth) disease. Possible for disease to not manifest until later in life.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How severe are immunodeficiencies?

A

Depending upon which component is failing determines the type of immunodeficiency and the severity. Some immunodeficiency disorders are relatively minor requiring little or no treatment, whereas others are life threatening and require major intervention.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How many people do immunodeficiencies affect?

A

1 in 10,000 births. They can be recessive, dominant, or x-linked. Most are x-linked therefore they are more common in males than females.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How can the type of recurrent infection inform which immune cell is affected?

A

-Bacteria indicate defects of antibody, complement, phagocytic defects
-Viral suggest T-cell defects
-Fungal suggest T-cell defects
-Autoimmunity can be main symptom

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How many immunodeficiencies are there?

A

Over 350.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is a IgA deficiency?

A

IgA deficiency is a relatively common disorder due to failure IgA bearing lymphocytes to differentiate into plasma cells. Many individuals with IgA deficiency are clinically asymptomatic but those with symptoms have sinopulmonary and gastrointestinal infections. These individuals are at risk of developing anti-IgA antibodies when given blood products. Occurs in 1 in 700 Caucasians but rare in other ethnic groups.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is a IFN-γ deficiency?

A

IFN-γ is the main cytokine that activates macrophages. Macrophages are important for defence against intravascular bacteria such as mycobacteria. IFN-γ is secreted by NK cells (innate immunity) and TH1 CD4+ and cytotoxic CD8+ cells (adaptive immunity). When IFN-γ binds to IFN-γ Receptor it causes increased phagocytosis and bacterial killing by activating JAK1 and JAK2 pathways. Patients with IFN-γ receptor deficiency due to recessive mutations of IFN-γ R1 genes have no R1 polypeptides on the cell surface, so cannot respond to IFN-γ .

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What do dominant IFN-γ deficiency cause?

A

Dominant mutations of IFN-γ R1 cause truncated cytoplasmic tails so they are unable to bind and activate JAK1 signalling (but can still bind IFN-γ). Because only need one mutant allele for a dominant condition 25% of receptors are normal so blood monocytes still response to IFN-γ (but less than healthy people). This form of disease is less severe and usually diagnosed later than those resulting from recessive mutations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What affect do antibody deficiencies cause?

A

Encapsulated pyogenic bacteria (e.g. Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus) are not recognized by phagocytic receptors of macrophages and neutrophils, so need to bound by specific antibody and complement first, then ingested and killed by phagocytes. Patients with antibody deficiency have lasting, recurrent pyogenic infections until given antibiotics.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is x-linked agammaglobulinaemia?

A

A rare disease where the body is unable to produce immunoglobulins. It produces a susceptibility to opportunistic infection due to the failure of humoral antibodies (cell-mediated immunity is unaffected). XLA was the 1st immunodeficiency identified (also known as Bruton’s disease). Bruton’s tyrosine kinase (Btk) is involved in intracellular signalling from the B-cell receptor, causing maturation of pre-B cells. Mutant Btk causes the B-cells to be arrested at the pre-B-cell stage and the production of Ig is grossly depressed (All classes of Ab affected). B-cells are reduced or absent in the peripheral blood and there are few lymphoid follicles or plasma cells in the lymph nodes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What does x-linked agammaglobulinaemia result in?

A

-Unable to produce functional B cells in males
-Females are carriers but healthy
-Ig production is grossly reduced
-Affected boys initially protected by passive immunity for first few months life due to transfer of maternal antibodies via placenta
-Recurrent pyogenic bacterial infections
-Cell-mediated immunity is normal so viral infections are dealt with

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How is x-linked agammaglobulinaemia treated?

A

-Antibiotics
-Intravenous Ig administration (passive immunity) against all common pathogens every 3-4 weeks to maintain adequate concentrations of circulating Ig to prevent tissue damage caused by the excessive release of proteases from both the infecting bacteria and defending phagocytes. This is particularly problematic in the lungs and can cause chronic inflammation known as bronchiectasis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is x-linked hyper IgM syndrome?

A

Mutations of CD40L (AKA CD154) on CD4+ T cells so cannot bind CD40R on B cells so cannot activated B cells so no class switching or memory cells. Abnormally high IgM circulating levels and very low or absent IgG, IgA and IgE. Recurrent pyogenic infections.

22
Q

How is x-linked hyper IgM syndrome treated?

A

Treated with regular intravenous immunoglobulin infusions and antibiotics. Also given granulocyte-macrophage-colony stimulating factor (GM-CSF) to overcome neutropenia as macrophage activation also requires macrophage CD40 binding with T cell CD40 Ligand so cannot produce GM-CSF needed for neutrophil production.

23
Q

How are immunoglobin deficiencies diagnosed?

A

-Quantitative measure of Ig
-Screen serum for natural antibodies
-Attempt to induce active immunity but not using live vaccines
-Enumerate B cells by immunophenotyping- CD19 (B cell co-receptor complex, found on B cells), CD20 (B cells) and CD22 (B cells)

24
Q

How do complement deficiencies impair immunity?

A

All the effector functions that antibodies use to clear pathogens are helped by complement activation so this means you get similar recurrent infection to what is seen in antibody immunodeficiency. Defects in C3 and its activation result in lots of pyogenic infections because C3 acts as an opsonin-enhancing removal of bacteria by phagocytosis whereas defects in C5-C9 (which are used at the end of the complement pathway to produce the membrane attack complex) don’t have much affect other than increased susceptibility to Neisseria as complement mediated lysis is the best way of dealing with Neisseria. Early complement proteins (C1-4) in the classical complement pathway are important for producing C4B and C3b which help eliminate immune complexes. Deficiencies in C1-4 cause an accumulation of immune complexes in the circulated deposition of the complexes in tissue, damaging it, and activating phagocytes which causes inflammation, and more damage. This is known as immune complex disease.

25
Q

What is opsonin?

A

An antibody or other substance which binds to foreign microorganisms or cells making them more susceptible to phagocytosis.

26
Q

What affect does phagocytic cell deficiencies cause?

A

Phagocytosis by macrophages and neutrophils is the main way of removing pathogens. So any deficiency that affects the phagocytes activity has an important effect on the ability to deal with infections.

Chediak-Higashi disease:
-Autosomal recessive
-Phagocytes defective in chemotaxis, phagocytosis,& microbicidal activity
-NK cell lack cytotoxic activity

Leukocyte adhesion deficiency:
-Lack of CD18 β-subunit of β2 integrins-LFA-1
-Phagocytes cannot bind endothelial cells and migrate to infected tissue
-Susceptible to recurrent infections-severity varies

27
Q

What is chronic granulomatous disease?

A

This is a phagocytic disorder. Due to mutations in 1 of 4 proteins forming NADPH (nicotinamide adenine dinucleotide phosphate) oxidase which produces hydrogen peroxide. Monocytes, macrophages & neutrophils cannot produce the superoxide radical O2-Reactive Oxygen Species so cannot kill intracellular organisms. Can be X-linked or autosomal recessive.

28
Q

What genes are responsible for CGD?

A

The cytochrome b558 component in the membrane is composed of p22phox and gp91phox (phagocyte oxidase) components. 70% of CGD patients have mutations of gp9191phox, which is located on the x chromosome. The remaining cases result from mutations in one of the other four components whose genes are located on various autosomal chromosomes.

29
Q

What is CGD characterised by?

A

CGD is characterised by defective respiratory burst which is the increased oxidative metabolism which occurs in phagocytic cells following activation. Activation of NADP/cytochrome oxidase is measured by superoxide anion production following stimulation with phorbol ester. In most mutations of gp91phox, no cytochrome is produced, however, there is a mutation of gp91 that enables low levels of the cytochrome to be produced and consequently a very low production rate of superoxide which can then be improved using gamma interferon. Carriers of this x-linked disease demonstrate intermediate levels of protein.

30
Q

What are the symptoms of CGD?

A

-Recurrent bacterial infection (Staphylococcus aureus, some gram –ve, some fungi Aspergillus fumigatus and Candida albicans)
-Recurrent infections can lead to granuloma which can obstruct gastrointestinal and urogenital systems
-Poor Antigen Presenting Cell function
-Pneumonitis

31
Q

How is CGD diagnosed?

A

-Stimulation of superoxide production using the phorbol ester is one of the methods used to diagnose CGD
-Nitroblue tetrazolium (NBT) assay. Following phorbol myristate acetate stimulation, reduction of yellow NBT to blue black formazan occurred in the healthy control cells, but is completely absent in cells from a patient with X-linked chronic granulomatous disease. The mother of the patient is a carrier of the mutation and has both NBT-positive and -negative cell populations (light red).

32
Q

How is CGD treated?

A

-Prophylactic antibiotics and antifungals
-Interferon γ to stimulate the production of superoxide
-Bone marrow transplantation but high risk of mortality, more conservative methods are probably better

33
Q

Why do defects in T cells cause greater impairment than B cells?

A

Defects in T cells often have a greater impact on the immune system than those that affect the B cells or innate responses. This is because T cells have an important role in directing the immune response so defects will often affect both humoral and cell mediated responses.

34
Q

What is SCID?

A

-Severe combined immunodeficiency
-Affects 1 in 80,000 live births
-Usually have a total failure of T cell development resulting in defective cell-mediated and humoral immunity
-Will die during first year of life without medical intervention

35
Q

What are the symptoms of SCID?

A

-Recurrent viral, bacterial, fungal, protozoan infections lymphopenia
-Prolonged diarrhoea from gastrointestinal infections
-Pneumonia
-Skin and mouth infections (Candida albicans)
-If vaccinated with live, attenuated organisms (such as measles) usually causes death from progressive infection

36
Q

What is lymphopenia?

A

Lymphopenia is a reduction in the number of lymphocytes.

37
Q

What gene defects cause SCID?

A

Mutations in several genes cause SCID (γc chain, ADA, artemis), which involves a block in T cell development, together with a direct or indirect B cell deficiency. In some cases NK cells also fail to develop.

38
Q

What is the cause of SCID based on the different gene mutations?

A

γc chain - defective cytokine signalling. Jak-3 transduces the γc signal
Artemis - no TCR or Ig gene rearrangement so no mature lymphocytes produced
ADA - toxic metabolite in T and B cells

39
Q

What is the recptor of the yc chain?

A

Cell-surface receptors IL-2, IL-4, IL-7, IL-9, and IL-15 cytokines.

40
Q

What is the treatment of SCID?

A

-Die before 1 year unless they receive medical intervention
-Hemopoietic stem cell transplant (bone marrow, peripheral blood, cord blood) is treatment of choice if a suitable match is available
-Patients with adenosine deaminase deficiency (ADA SCID) without a suitable HSCT match receive weekly ADA enzyme replacement therapy
-If B cells affected then intravenous immunoglobulins are given every 3-4 weeks
-Gene therapy when a matched transplant is not available (mainly with ADA-SCID and more recently γc chain cytokine receptor gene)

41
Q

What are the affects of a T cell deficieny?

A

-Opportunistic infection
-Poor humoral immunity
-Allergies
-Lymphoid malignancies
-Autoimmune diseases (inefficient negative selection in thymus, failure to generate T regulatory cells)

42
Q

How are T cell deficiencies diagnosed?

A

-Hypo- or unreactive in skin tests to tuberculin, Candida and mumps
-Phytohaemagluttin activation of T-lymphocytes
-Enumeration of T cells by immunophenotyping-CD3 (TCR on T cells), CD4 (MHC class II receptor on T cells) and CD8 (MHC class I receptor on T cells)

43
Q

What is the T cell DiGeorge (Velocardiofacial) syndrome?

A

Developmental disorder affecting thymus (failure of the thymus to develop properly from the third and fourth pharyngeal pouches).

Other features:
-Lack parathyroid
-Severe heart abnormalities
-Immunodeficiency
-Moderate learning difficulties
-Fish-like mouth
-Down-slanting palpebral fissures
-1 in 4,000 births

44
Q

What is the cause of a lack of a thymus in DiGeorge syndrome?

A

Lack of thymus causes:
-No T cells
-Sparsely populated lymphoid tissue (thymus-dependent areas)
-Poorly developed lymphoid follicles
-No cell-mediated immunity
-Subnormal antibody response

45
Q

What is the treatment of DiGeorge syndrome?

A

Total Aplasia:
-Total aplasia is rare
-Grafting neonatal thymus restores immune function (immunocompetence)
-Antibody administration (passive immunity)

Partial Hypoplasia:
-Partial hypoplasia is more common
-T-cells increase from 6% at birth to ~30% of total circulating lymphocytes at 1 year (compared with 60-70% in normal 1 year olds)
-Normal antibody responses
-No immunological intervention required

46
Q

How is DiGeorge syndrome diagnosed?

A

DiGeorge syndrome can be diagnosed or suspected by karyotype analysis and then confirmed by FISH. The chromosome on the right in each pair is shorter than the one on the left. This is due to the deletion of a bright band in the long arm of the chromosome to the right, near the centromere. Deletion of the TBX1 gene is what causes DiGeorge syndrome. TBX1 is a transcription factor that is highly expressed during the phases of embryonic development when the facial structures, heart, thyroid, parathyroid, and thymus are forming.

47
Q

List of syndromes associated with the inefficient killing of ingested pathogens?

A

G6PD deficiency
CGD
MPOD

48
Q

When is the autoimmune disease hereditary angioedema (HAE) manifested?

A

HAE is an autosomal dominant disease associated with a defect in the C1INH gene. The unaffected allele is unable to produce adequate amounts of C1INH to regulate complement and clotting cascades. Patients are treated with recombinant human C1INH proteins.

49
Q

MHC class II deficiency is associated with a homozygous defect in which of the following?

A

In patients with MHC class II deficiency, CD4 T cells fail to develop due to the absence of interactions with self-MHC class II molecules in the thymus. The lack of CD4 T cells compromises most aspects of adaptive immunity. This deficiency arises from defects in four transcriptional regulators that contribute to the expression of all the HLA class II genes. A homozygous defect in any one of the four proteins produces the condition. These comprise the class II transactivator (CIITA) and three components of RFX, the transcriptional complex that binds to the X box, a conserved sequence in the promoter of HLA class II genes.

50
Q

MHC class I deficiency is associated with a homozygous defect in which of the following?

A

A defect in either one of the two proteins forming the TAP peptide transporter impedes peptide binding by HLA class I, leading to an abnormally low level of cell-surface HLA class I. This syndrome, MHC class I deficiency, is less severe than that observed in MHC class II deficiency, its principal effect being a reduced number of CD8 T cells and diminished cytotoxic T-cell responses to intracellular infections.

51
Q

What is Wiskott-Aldrich syndrome?

A

Another X-linked deficiency of T-cell function is Wiskott–Aldrich syndrome (WAS), a condition involving the impairment of platelets as well as lymphocytes. It is diagnosed in childhood as a history of recurrent infections that are immunologically less severe than those characterizing SCID. The patients have normal levels of T and B cells but make inadequate antibody responses and are therefore kept on a course of intravenous immunoglobulin. The disease-causing mutation affects the Wiskott–Aldrich syndrome protein (WASP). WASP contributes to the cytoskeletal reorganization that T cells undergo in forming cognate interactions with B cells, macrophages, and other target cells.